Trust Company of Toledo’s GSK GSK Stock Holding History

Trust Company of Toledo’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.79M	Buy	34,116 +1,197	+4%	+$63.3K	0.15%	128
2026 Q1	$1.82M	Buy	32,919 +302	+0.9%	+$16.4K	0.17%	118
2025 Q4	$1.6M	Buy	32,617 +1,162	+4%	+$54.2K	0.16%	119
2025 Q3	$1.36M	Buy	31,455 +650	+2%	+$25.4K	0.14%	145
2025 Q2	$1.18M	Buy	30,805 +797	+3%	+$30.5K	0.13%	146
2025 Q1	$1.16M	Buy	30,008 +2,135	+8%	+$78.2K	0.15%	133
2024 Q4	$943K	Sell	27,873 -4,806	-15%	-$173K	0.12%	141
2024 Q3	$1.34M	Buy	32,679 +2,015	+7%	+$82.4K	0.18%	124
2024 Q2	$1.18M	Buy	30,664 +6,030	+24%	+$254K	0.17%	122
2024 Q1	$1.06M	Buy	24,634 +6,696	+37%	+$276K	0.17%	125
2023 Q4	$665K	Buy	+17,938	New	+$644K	0.11%	145

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Trust Company of Toledo's GSK Position: Q2 2026 in Review

Trust Company of Toledo increased its GSK (GSK) stake by 3.6% in Q2 2026, buying an estimated $63.3K and bringing the position to 34,116 shares worth $1.79M. The position accounts for 0.15% of the portfolio, ranked #128.

Trust Company of Toledo first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.82M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Trust Company of Toledo held 34,116 shares of GSK worth $1.79M as of Q2 2026.
Trust Company of Toledo bought 1,197 GSK shares in Q2 2026, an estimated $63.3K.
GSK made up 0.15% of Trust Company of Toledo's portfolio in Q2 2026, its #128 holding.
Trust Company of Toledo first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
Trust Company of Toledo's GSK position peaked at $1.82M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.